Skip to content
Saturday 18 July 2026EN · DE
City PM

European business, markets and politics

  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Monday 10 May 2021 8:05 pm  |  Updated:  Monday 10 May 2021 10:05 pm

Hospitals across India report Covid-19 patients with rare deadly black fungus that decays brains and lungs

By: Michiel Willems

Add as a preferred source on Google
Source: Getty Images

Dozens of hospitals across India have started to report cases of Coronavirus patients being hit by a rare black fungus which has a mortality rate of about 50 per cent.

A number of severely ill Covid-19 patients are showing symptoms of Mucormycosis, an extremely rare fungal infection, which causes vital organs to rot, including the brain, lungs and sinuses.

According to a report earlier today in The Hindustan Times, one of India’s largest newspapers, the country’s governmental Council of Medical Research warned doctors in recent days to look out for symptoms, such as blackening or discolouration over the nose, blurred or double vision, chest pain, toothache and loosening of teeth, breathing difficulties and coughing blood.

The fungus is usually found in decaying fruits and vegetables and certain soils, often at markets and in agricultural settings.

Surge since India’s Covid-19 crisis

Before the outbreak of the coronavirus pandemic, Mucormycosis was close to non-existent, with only a few known cases reported every year.

However, since Covid-19 spiralled out of control in India last month, hospitals and clinics have started to report multiple cases a day, according to The Indian Express newspaper today.

Some doctors have had to remove infected jaw bones, noses and eyes in order to save patients, namely to prevent the mucor from spreading to the brain.

“Mucormycosis is now playing absolute havoc. We are seeing four to five new patients every day and have around 35 patients still admitted,” Dr Prashant Rahate, the chairman of Seven Star Hospital in the city of Nagpur, told The Telegraph today.

The hospital has reportedly treated more black fungus patients than any other clinic in India.

According to data from the US Center for Disease Control and Prevention, black fungus has a mortality rate of around 50 per cent. Early diagnosis and treatment significantly improve survival chances.

Read more

Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus

Trending Articles

  • Revealed: KPMG and Deloitte offer bumper redundancy packages to slash headcount

  • James Watt offers to buy back Brewdog

  • Citroën 2CV returns as a £13,000 electric car, and the timing is no accident

  • Motsepe backed to succeed Fifa’s Infantino by South African minister

  • Brewdog owner shrugs off James Watt takeover bid

More from City PM

  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe

    Business Wire
  • Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

    Business Wire
  • Mosaic Clinical Technologies™ Launches Mosaic Reporting™, an AI-Native Reporting Platform Built for Radiology Workflows

    Business Wire
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

    Business Wire
  • Semble Secures £30M Series C Investment Led by Revaia to Expand Europe’s Connected Healthcare Platform

    Business Wire
  • Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook